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Jiang).We investigated membrane targeting of the P2X7 receptor (P2X7R) in polarized epithelial cells using
immunoﬂuorescent confocal imaging. The wild-type receptor was targeted to the basolateral mem-
brane, independently of adaptor protein l1B. Deletion of the majority of the intracellular C-termi-
nus, or the last 26 residues (P570-Y595), conferred targeting of the protein to the apical membrane.
Alanine substitution in the microdomain P582-Q587 caused similar apical membrane targeting
without major effect on the receptor function and surface expression. Our results show basolateral
membrane targeting of the P2X7R in epithelial cells and that the intracellular C-terminal microdo-
main P582-Q587 is crucial in this process.
Structured summary:
MINT-8055849:Beta-catenin (uniprotkb:B6V8E6) and P2X7R (uniprotkb:Q64663) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
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The P2X7 receptor (P2X7R) for extracellular ATP is abundantly
expressed in immune cells and plays a crucial role in release of
inﬂammatory cytokines [1–3]. In normal kidney, P2X7R expression
level is usually low or undetectable but increases dramatically in
rodent models of renal pathologies such as polycystic kidney dis-
ease [4,5]. Up-regulated P2X7R expression has also been reported
in patients suffering from autosomal recessive polycystic kidney
disease and inﬂammatory bowel disease [5,6]. These ﬁndings con-
stitute compelling evidence supporting a role of the P2X7R in the
pathogenesis of some epithelial diseases. The plasma membranes
of epithelial cells are asymmetric or polarized, and are composed
of basolateral and apical domains that are separated by tight junc-
tions and which possess distinctive membrane protein and lipid
compositions. There has been signiﬁcant progress in decipheringchemical Societies. Published by E
ey epithelial cells; LLC-PK1,
ic kidney; DMEM, Dulbecco’s
escent protein; WT, wild-type
), l.h.jiang@leeds.ac.uk (L.-H.the molecular machineries targeting proteins to the apical and
basolateral membranes and particularly in identifying basolateral
targeting motifs within proteins [7,8]. Immunostaining studies
demonstrate that the P2X7R is present in the apical membrane of
tubular cells in the cortex and medulla, and also intracellularly in
some proximal tubules [3,4]. The molecular basis governing
P2X7R targeting in polarized epithelial cells is unknown. Here,
using immunoﬂuorescent confocal imaging, we studied localiza-
tion of the recombinant P2X7R in polarized epithelial cells. Our re-
sults show basolateral membrane targeting of the P2X7R and
identify an intracellular C-terminal microdomain P582-Q587 that
is crucial in this process.
2. Materials and methods
2.1. Chemicals and clones
Chemicals were purchased from Sigma unless indicated other-
wise. The plasmids encoding wild-type (WT) and truncation
mutant rat P2X7Rs with a C-terminal EE (EYMPME) epitope
were from previous studies [9,11]. Alanine substitutions were
introduced by site-directed mutagenesis and conﬁrmed by
sequencing.lsevier B.V. All rights reserved.
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Madin-Darby canine kidney epithelial cells (MDCK strain II),
porcine kidney epithelial cells (LLC-PK1), and human embryonic
kidney (HEK293) cells were maintained in Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM) supplemented with 10% foetal bovine ser-
um (Invitrogen) at 37 C in a humidiﬁed 5% CO2 incubator. For
electrophysiological studies, HEK293 or MDCK cells in a 35 mm
petridish were co-transfected with 1 lg of P2X7R plasmid and
0.1 lg of enhanced green ﬂuorescent protein (GFP) plasmid. Cells
were dispersed on coverslips after transfection and used within
24–48 h. HEK293 cells for biotin-labelling and immunostaining
were transfected in the same way, except for omission of GFP plas-
mid for immunostaining experiments. Conﬂuent MDCK and LLC-
PK1 cells grown on 24.5 mm-Transwell ﬁlters (0.4 lm pore size;
Costar) were transfected with 1–2 lg of P2X7R plasmid and used
24 h later. Transfection was performed using lipofectamine2000
according to the manufacturer’s instructions (Invitrogen). Based
on the GFP-positive cells, the transfection efﬁciency for MDCK cells
(5–10%) was much lower than that of HEK293 cells (>50%).
2.3. Electrophysiological recording
Whole-cell inward currents were recorded using an Axopatch
200B ampliﬁer as described previously [10]. Extracellular solution
contained (concentrations in mM) 147 NaCl, 2 KCl, 1 MgCl2, 2
CaCl2, 10 HEPES and 13 glucose, pH 7.3, and intracellular solution
contained 145 NaCl, 10 EGTA and 10 HEPES, pH 7.3. ATP was ap-
plied via a RSC160 rapid solution changer (BioLogic Science
Instrument).
2.4. Immunoﬂuorescent confocal imaging
Immunostaining of HEK293 cells was performed using primary
rabbit anti-EE antibody (1:1000; Bethyl) and secondary Alexa
488-conjugated goat anti-rabbit IgG antibody (1:1000–1:2000;
Molecular Probes) as detailed previously [11]. Immunostaining of
MDCK and LLP-PK1 cells, monolayers were ﬁxed with 4% parafor-
maldehyde in PBS containing 5% goat serum (PBS/GS) (or bovine
serum albumin in some experiments), washed thrice in PBS/GS,
then permeabilized with 0.1% Triton X-100 in PBS/GS for 10 min.
Cells were then incubated in PBS/GS for 1 h before incubating with
primary rabbit anti-EE antibody (1:1000; Bethyl) andmouse anti-b-
catenin (1:500; BD Sciences) in PBS/GS for 24 h at 4 C, washed in
PBS, and then incubated with secondary Alexa 488-conjugated goat
anti-rabbit IgG (1:1000, Molecular Probes), and Cy5-conjugated
goat anti-mouse IgG (1:250; Jackson) antibody for 1 h at room tem-
perature. Finally, monolayers were incubated with lectins (tetra-
methyl rhodamine iso-thiocynate-conjugated peanut agglutinin
and wheat germ agglutinin: 1:500; Vector Labs) in PBS/GS for
30 min. The ﬁlters were removed and mounted using Vectashield
(Vector Labs). Imageswere captured using a ZeissMeta 510 confocal
microscope and processed using Zeiss LSM image browser software.
2.5. Biotin-labelling and Western blotting
Biotin-labelling was carried out by modifying the protocols de-
scribed in our previous studies [12]. In brief, transfected HEK293
cells were labeled with sulfo-NHS-LC-biotin (Pierce) for 30 min at
4 C before they were lysed in lysis buffer. Total protein concentra-
tions in lysate were determined using the bicinchoninic acid pro-
tein assay (Thermo Scientiﬁc). The biotin-labeled proteins were
puriﬁed from total 200 lg protein by incubating the lysate with
EZ view red streptavidin afﬁnity beads (Sigma) overnight at 4 C,
and were eluted in 50 lL protein electrophoresis buffer (6% SDS,
10% glycerol, 50 mM Tris–HCl pH 6.8, 2 mM ETDA, 0.05% bromo-phenol blue and 10% b-mercaptoethanol). Whole cell lysate
(10 lg) or biotin-labeled samples (30 lL) were separated on 12%
SDS–PAGE gels. Proteins were detected using primary rabbit anti-
EE antibody (1:5000; Bethyl) or mouse anti-GFP (1:2000; Santa
Cruz) antibody and secondary horseradish peroxidase-conjugated
anti-rabbit (1:5000) or anti-mouse IgG (1:2000) antibodies (Santa
Cruz). LLC-PK1 cells were lysed in lysis buffer at 4 C for 30 min,
and proteins in the cell lysates were detected using primary rabbit
polyclonal anti-l1B antibody (1:1000) and secondary horseradish
peroxidase-conjugated anti-mouse IgG antibody (1:1000; Dako).
2.6. Data analysis
All data, where appropriate, are presented as mean ± S.E.M. The
EC50 for ATP was estimated by ﬁtting the data from individual cells
to the Hill equation: I = 100/[1 + (EC50/[ATP])n], where I is the cur-
rent at a given [ATP] expressed as percentage of maximum, and n is
the Hill coefﬁcient. Curve ﬁtting was performed using Origin and
statistical analysis using Student’s t-test.3. Results
3.1. Functional expression of P2X7R in non-polarized HEK293 and
MDCK cells
It is well-established that transfection of HEK293 cells with
P2X7R plasmids results in robust functional P2X7R expression
[e.g., 9–11]. We therefore determined whether this was achievable
in MDCK cells. Fig. 1A shows currents evoked by 3 mM ATP, a max-
imal concentration for the rP2X7R [9]. Such currents were not ob-
served in non-transfected cells. These results show functional
P2X7Rs were expressed in MDCK cells although the maximal
ATP-induced currents were relatively lower than in HEK293 cells
(Fig. 1A).
3.2. Basolateral targeting of P2X7R in MDCK and LLC-PK1 cells
We determined the localization of P2X7Rs in polarized MDCK
and LLC-PK1 as well as HEK293 cells. As observed in previous stud-
ies [10–12], the P2X7R immunoreactivity in HEK293 cells was uni-
formly concentrated in or close to the plasma membrane (Fig. 1B),
and such immunoreactivity was completely absent in non-trans-
fected cells (data not shown). In polarized MDCK cells, the P2X7R
immunostaining was observed in transfected cells, and strongly
co-localized with b-catenin, the basolateral membrane marker,
but not with lectins, the apical membrane markers (Fig. 1C). To
examine whether such basolateral localization was MDCK cell-
speciﬁc and involved the adaptor protein l1B that is endogenously
expressed in MDCK cells [7], we repeated these experiments in
LLC-PK1 cells devoid of (WT) or stably expressing l1B [13]. The
l1B expression was veriﬁed by Western blotting (Fig. 1D). In both
cell lines, the P2X7R was targeted to the basolateral membrane
(Fig. 1E), suggesting that the basolateral targeting of P2X7R is not
cell speciﬁc and is independent of l1B.
3.3. Apical localization of P2X7Rs with deletion of intracellular C-
terminus
In contrast with the P2X7R, the P2X2R was targeted to the apical
membrane (Fig. 1F). The P2X4R was also targeted to the apical do-
main but mainly resided intracellularly (Fig. 1G). Both the P2X2R
and P2X4R possess shorter C-termini than the P2X7R [1], suggest-
ing that the P2X7R may contain a dominant basolateral targeting
motif within its extended C-terminus. We thus examined two
truncated receptors, P2X7R-D418 which lacks the majority of the
Fig. 1. Function and localization of P2X7R in HEK293, MDCK and LLP-PK1 cells. (A) ATP-induced currents in HEK293 and MDCK cells expressing P2X7Rs. (B) Confocal image
showing uniform surface expression of P2X7Rs in HEK293 cells: ﬂuorescent image (left), phase contrast image (middle) and merged image (right). (C) Confocal images
showing basolateral targeting of P2X7Rs (green) in a monolayer of MDCK cells. Upper row shows the X–Y section and bottom row the X–Z section from the dotted lines, and
lectins (red) and b-catenin (blue) are the apical and basolateral membrane markers, respectively. (D) Western blot showing LLP-PK1 cells without and with l1B expression
(denoted by arrowhead). (E) Confocal images showing basolateral targeting of P2X7Rs (green) in monolayers of LLP-PK1 cells with or without l1B expression. (F and G)
Confocal images showing expression of P2X2Rs (F) and P2X4Rs (G) in MDCK cells. The scale is 10 lm.
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last 26 residues (Fig. 3A). Both mutants were mainly targeted to
the apical domain (Fig. 2B–C), suggesting that the distal C-terminal
microdomain (P570-Y595) is critical for basolateral targeting.
3.4. Effects of alanine substitution in P570-Y595 on P2X7R targeting
and function
The P570-Y595 microdomain contains a canonical basolateral
targeting motif Y588-S589-G590-F591 (YxxU,U denoting a hydro-
phobic residue; 7, 14) (Fig. 3A). To further study the role of this
microdomain, and particularly this basolateral targeting motif,
we introduced triple or double alanine substitutions. Substitution
of P570-Q587 conferred targeting to the apical domain with muta-
tion speciﬁc subcellular location in MDCK cells: P570A/S571A/
C572A, C573A/R574A/W575A and K576A/I577A/R578A mutants
were mainly intracellular, whereas P582A/K583A/T584A and
Q585A/G586A/Q587A mutants were in the apical membrane
(Fig. 2D–I). In contrast, alanine replacement of the last eight resi-
dues (Y588-Y595) was without effect; the mutant receptors were
targeted to the basolateral membrane as was the WT receptor
(Fig. 2J–L). These results suggest that P570-Q587 but not YSGF is
critical in basolateral targeting of the P2X7R.
To elaborate these ﬁndings further, we examined the muta-
tional effects on the P2X7R function by measuring ATP-induced
currents from cells expressing the WT or mutant receptors. This
was carried out in HEK293 cells, due to very poor efﬁciency of
transfecting MDCK cells (see Methods and Materials), but the
functional phenotypes are presumably independent of the celltypes. Indeed, alanine substitution of P570-F581 almost com-
pletely abolished or strongly reduced the receptor function
(Fig. 3B), in agreement with intracellular localization of the resul-
tant mutants in MDCK cells (Fig. 2D–G). In contrast, substitution
of F582-Y595 resulted in no reduction in the ATP-induced currents
with the exception that slight enhancement by mutating F591-
Y595 (Fig. 3B), consistent with their targeting to the plasma mem-
branes in MDCK cells (Fig. 2H–J). Furthermore, mutation of P582-
Y595 introduced no or small (6two-fold) change in the sensitivity
to ATP or the EC50 value (Table 1). Finally, we performed biotin-
labelling to verify directly the membrane expression of P582A/
K583A/T584A and Q585A/G587A/Q588A mutants. Both mutant
receptors exhibited substantial expression at the cell surface
although there was some noticeable change in comparison to the
WT receptor (Fig. 3C).
Taken together, the results described above indicate that
P582A/K583A/T584A and Q585A/G587A/Q588A mutations cause
no major effect on the receptor function, but switch to apical mem-
brane targeting in striking contrast with basolateral membrane
presence of the WT receptor. These results thus provide strong evi-
dence to suggest that P582-Q587 is critical in basolateral targeting
of the P2X7R.4. Discussion
In this study we show heterologous expression of functional
P2X7Rs in MDCK cells as well as in the widely used HEK293 cells
(Fig. 1A and B). More importantly, the present study is the ﬁrst
Fig. 2. Effects of deletion of the intracellular C-terminus and alanine substitution
within the P570-Y595 domain on P2X7R targeting. Confocal images showing
targeting of wild-type, indicated deletion and point mutant P2X7Rs. Upper row
shows the X–Y section and bottom row the X–Z section from the dotted lines, and
lectins (red) and b-catenin (blue) are the apical and basolateral membrane markers,
respectively. The scale is 10 lm.
Table 1
Summary of effects of alanine substitution of K579-Y595 on the ATP sensitivity.
P2X7R EC50 (lM) EC50,mut/EC50,WT nH Cell no.
WT 132 ± 7.5 1.7 ± 0.1 6
K579A/E580A/F581A 228 ± 11* 1.7 1.4 ± 0.1* 4
P582A/K583A/T584A 185 ± 9.1 1.4 1.9 ± 0.1 4
Q585A/G586A/Q587A 82 ± 6.1* 0.65 2.7 ± 0.1* 5
Y588T/S589A/G590A 146 ± 15 1.1 1.5 ± 0.1 4
F591/K592A/Y593A 58 ± 3.2* 0.44 1.8 ± 0.1 4
P594A/Y595A 65 ± 6.4* 0.49 2.0 ± 0.1 4
* P < 0.01 compared to WT.
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basolateral membrane in polarized MDCK and LLP-PK1 cells
(Fig. 1C and E). Furthermore, despite the well-documented impor-
tance of interactions with the adaptor protein l1B in sorting baso-
lateral membrane proteins [7], we show that the P2X7R remains
basolateral in LLP-PK1 cells lacking l1B (Fig. 1E). These results
strongly indicate that basolateral targeting of the P2X7R is not a
cell speciﬁc phenomenon and is mediated via l1B-independent
mechanisms.The contrasting domain localization of the P2X7R versus the
P2X2R and P2X4R (Fig. 1F and G) provides further evidence to dis-
credit erratic domain targeting and instead suggests a basolateral
targeting signal in the P2X7R-speciﬁc C-terminus that is dominant
over an apical signal(s) present in the more conserved part of the
receptor. Indeed, the apical expression of the deletion mutants
P2X7R-D418 and P2X7R-D570 (Fig. 2B and C) enabled us to localize
the basolateral targeting signal to the distal C-terminal microdo-
main P570-Y595. Alanine substitution of the N-terminal part of
this microdomain (P570-F581) conferred apical domain targeting
and, of notice, the resultant mutant proteins exhibited intracellular
residence (Fig. 2D–G) and were non-functional, as evidenced by
loss of ATP-induced currents (Fig. 3B). Previous studies in
HEK293 cells, by introducing domain deletions and point mutation,
show that the P570-F581 microdomain, and particularly the diba-
sic motif R578-K579, are critical in membrane trafﬁcking and func-
tion [15,16]. Clearly, our results are consistent with these studies.
The C-terminal part of this microdomain (P582-Y595) possesses
a canonical basolateral targeting motif YxxU [7,14] (Y588-S589-
G590-F591) (Fig. 3A). Alanine substitution of P582-Y595 had no
or very mild effect on the receptor function as shown in examining
the ATP-induced maximal currents and ATP sensitivity (Fig. 3B and
Table 1). However, the mutations induced a clear transition in the
membrane targeting: apical for P582A/K583A/T584A, largely apical
but noticeably basolateral for Q585/G586A/Q587A, and predomi-
nantly basolateral for Y588A/S589A/G590A, F591A/K592A/Y593A
and P594/Y595 (Fig. 2H–L). In addition, the P582A/K583A/T584A
and Q585/G586A/Q587A mutants showed strong surface expres-
sion (Fig. 3C). These results suggest that P570-Q587 and particu-
larly P582-Q587 is critical in basolateral targeting of the P2X7R.
Interestingly, a recent study has reported basolateral targeting of
the ATP-sensitive metabotropic P2Y1 receptor that is also indepen-
dent of l1B but critically requires a stretch of 25 residues in the
distal intracellular C-terminus [14]. The ﬁndings from previous
and present studies suggest that the receptors for extracellular
ATP are directed to the basolateral membranes via motifs that
are distinct from those previously identiﬁed [7].
There are several PX7R alternative splicing variants [17–20]. The
P2X7R-B variant, which lacks the last 171 residues and differs in
the 18 residues immediately after the TM2, shows a similar tissue
and cell distribution as the full-length subunit studied here, and
can form functional homomeric receptors as well as heteromerize
with the full-length subunit [17,20]. The P2X7R-J variant, without
the entire intracellular C-terminus, the TM2 and the distal third
of the extracellular domain, is expressed in epithelial cells, where
it does not form functional receptors on its own, but can interact
with and suppress the activity of the full-length subunit [18]. Both
P2X7R-B and P2X7R-J are devoid of the basolateral targeting motif
identiﬁed here. Thus, it will be interesting to determine the target-
ing of the P2X7Rs formed by or containing such variants in epithe-
lial cells.
Our ﬁnding of basolateral targeting of the P2X7R in polarized
MKCK and LLP-PK1 epithelial cells is surprising, considering the
apical localization of the endogenous receptors reported in renal
tubular and intestinal epithelial cells (see Section 1). The exact rea-
son for this discrepancy is unclear. The P2X7R is also found at the
apical surface of the T84 intestinal epithelial cell line, but interest-
ingly undergoes substantial apical-to-basolateral translocation
during the early phase of trans-epithelial migration of polymor-
phonuclear leukocytes [6]. Thus, the intracellular milieu of the
receptor appears vital. The speciﬁcity of antibodies used in immu-
nostaining studies of the native P2X7Rs is under debate [21]. Rigor-
ous pharmacological characterization is required to reassure
assignment of the P2X7R immunoreactivity in the apical mem-
branes of tubular cells in the kidney.
Fig. 3. Effects of alanine substitution within the P570-Y595 domain on P2X7R function and surface expression. (A) A diagram illustrating the membrane topology of P2X7R
subunit. TM1 and TM2 denote the two transmembrane domains. Below is sequence alignment of the last 25 residues (P570-Y595) from human (H), dog (D), mouse (M), rat
(R) and guinea pig (GP) P2X7Rs. Residues in bold and italic are completely or highly conserved. YxxU is a canonical basolateral targeting motif, U denoting a hydrophobic
residue. (B) Summary of ATP-induced maximal currents in HEK293 cells expressing the WT and indicated mutant rP2X7Rs. The bars in grey indicate signiﬁcant difference
from WT (P < 0.05). (C) Western blots showing total (top) and surface protein expression (bottom) of the WT and indicated mutant rP2X7Rs. GFP expression was included as
an internal control for cell numbers, transfection and protein sample loading. Similar results were observed in two to three independent experiments.
4744 H.J. Bradley et al. / FEBS Letters 584 (2010) 4740–4744In conclusion, we show basolateral targeting of the P2X7R in
epithelial cells and such localization is governed by a basolateral
targeting motif in the distal intracellular C-terminus.
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